Blog Post

Blog Post

A Letter From Dr. Susan Apkon to the MDA Community: How Telehealth is Changing Medicine (and How to Prepare for It)

By Susan Apkon, MD | May 14, 2020
Blog Post

Clinical Trials During COVID-19: What We Need From the FDA

By Paul Melmeyer | May 12, 2020
Blog Post

This National Volunteer Week, Your Virtual Support of MDA Means Even More

By MDA Staff | April 17, 2020
Blog Post

MDA Advocacy in These Uncertain Times

By Mark Fisher | March 19, 2020
Blog Post

Acceleron Pharma Announces Discontinuation of Clinical Trials Program for CMT

By Jeanene Swanson | March 18, 2020
Blog Post

NS Pharma Launches Expanded Access Program for Viltolarsen

By Jeanene Swanson | March 9, 2020
Blog Post

What’s New for MDA Muscle Walk in 2020

By Lindsey Baker | March 5, 2020
Blog Post

Simply Stated: What is Inclusion-Body Myositis?

By Jeanene Swanson | February 28, 2020
Illustration of DNA
Blog Post

FDA Accepts NS Pharma’s NDA for Viltolarsen for the Treatment of DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | February 26, 2020
Blog Post

MDA’s New Chief Research Officer Sharon Hesterlee Shares Vision for the Future

By Jeanene Swanson | February 21, 2020